How to Buy Moonlake Immunotherapeutics Stock
Moonlake Immunotherapeutics
MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It is developing Sonelokimab, a novel investigational Nanobody therapy for the treatment of inflammation.
Moonlake Immunotherapeutics stock last closed at $42.84, up 4.72% from the previous day, and has increased 88.72% in one year. It has overperformed other stocks in the Biotechnology industry by 1.1 percentage points. Moonlake Immunotherapeutics stock is currently +110.52% from its 52-week low of $20.35, and -34.07% from its 52-week high of $64.98.
As of May 1, 2024, there are 63.89M shares of MLTX outstanding. The market capitalization of MLTX is $2.74B. In the last 24 hours, 363,653 MLTX shares were traded.
How to Buy Moonlake Immunotherapeutics Stock
Wondering how to invest in Moonlake Immunotherapeutics stock? Here's how.
- Figure out where to buy Moonlake Immunotherapeutics stock: You need to decide on an online brokerage, but don't worry - we've sifted through dozens of online stock brokerages and apps to help you decide where to buy Moonlake Immunotherapeutics stock.
- Sign up for your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've identified.
- Fund your brokerage account: Pick your payment method and add your details.
- Analyze Moonlake Immunotherapeutics stock: The Moonlake Immunotherapeutics ticker symbol is MLTX. Is Moonlake Immunotherapeutics stock a good investment? Should you buy shares of MLTX? How do MLTX's underlying business fundamentals look? Do top analysts think Moonlake Immunotherapeutics is a good buy? Why has MLTX's stock price moved recently? (Hint: Our stock market analysis tools can help you understand if MLTX is a good stock to buy).
- Place your MLTX buy order: Decide if you will purchase MLTX shares at the current market price or use a limit order to purchase MLTX shares at a particular price.
- Get the latest news on your MLTX position: Create a watchlist to important notifications about your position in Moonlake Immunotherapeutics stock.
Step 1: Figure out where to buy Moonlake Immunotherapeutics stock
You will need an online brokerage account in order to access the NASDAQ market and buy MLTX stock.
Our preferred brokerage: eToro
In our opinion, eToro is the best brokerage. Here's why:
- Invest in stocks with 0% commissions: Invest without commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still purchase the stock.
- Access to world markets: From Tech to Industrials, New York to London — you can fill your portfolio with stocks from the world's top stock exchanges.
- Social investing: eToro has a community with more than 20 million users around the world. Talk to, learn from, and copy the unique crypto portfolios of other investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your share purchase by creating an account with eToro now.
Open eToro AccountStep 2: Sign up for your brokerage account
Now that you've picked the right brokerage, you'll need to fill out some personal details so you are able to buy MLTX today.
How to Create a New Brokerage Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Input your personal details to create a new trading account.
- Submit your application by clicking the "Create Account" button. Get started with eToro today
Step 3: Fund your brokerage account
Now that you've finished signing up on the best stock market app, your next step is to transfer the money for your investment:
Check out the tutorial below for more details depositing funds into your new investment account.
Step 4: Analyze Moonlake Immunotherapeutics stock
After you have chosen the best place to buy Moonlake Immunotherapeutics stock, it's crucial to analyze their stock before you buy, so you can comprehend the risk as well as the upside.
Moonlake Immunotherapeutics Numbers
Moonlake Immunotherapeutics Due Diligence Checks
WallStreetZen was built to help everyday investors perform better fundamental analysis.
You can see all of the due diligence checks on MLTX's stock page.
What is the fair value of MLTX stock?
Investors use many financial metrics, analyses, models, and charts to gauge MLTX's intrinsic value.
Using relative valuations ratios:
- MLTX may be undervalued based on its P/B ratio of 5.52x, relative to Biotechnology industry P/B ratio of 6.02x
You can do additional valuation research on MLTX's stock here.
Is MLTX a healthy company?
Passed Financial Due Diligence Checks:
- MLTX has a low debt to equity ratio of 0.03.
- MLTX has cash burn of 43062801. It has enough cash and short-term investments to cover this for at least one year.
- There are more short-term assets than short-term liabilities on the MLTX balance sheet.
- MLTX has $511.01M in cash and short term investments. This is enough to cover its annual cash burn of $43.06M.
- There are more short-term assets than long-term liabilities on the MLTX balance sheet.
Is it a good time to buy MLTX stock, according to Wall Street analysts?
Out of 8 Wall Street analysts who research MLTX, the consensus analyst rating on MLTX is a Strong Buy
It's important to note that analyst forecasts are not recommendations, nor are they financial advice.
Most Recent MLTX Analyst Upgrades/Downgrades
Samantha Semenkow, a bottom 10% analyst from Citigroup initiates coverage on MLTX with a strong buy rating and announces their MLTX price target of $72.00, on Dec 8, 2023.
Yatin Suneja, a top 35% analyst from Guggenheim maintains MLTX with a strong buy rating and raises their MLTX price target from $70.00 to $77.00, on Nov 15, 2023.
Prakhar Agrawal, a top 13% analyst from Cantor Fitzgerald reiterates MLTX with a strong buy rating and maintains their MLTX price target from $78.00 to $78.00, on Nov 8, 2023.
You can dive deeper into what analysts are projecting on the Moonlake Immunotherapeutics stock forecast page.
MLTX Technicals
Latest Insiders Trades at MLTX
Over the last year, executives and large shareholders at MLTX have bought more shares than they have sold.
Da Silva Jorge Santos, Chief Executive Officer of MLTX, was the latest MLTX insider to sell. They sold $264,918.60 worth of MLTX stock on Feb 29, 2024.
Research more about who owns MLTX stock here.
Can I rely on MLTX as an income stream?
No, Moonlake Immunotherapeutics doesn't provide an income stream by paying out dividends.
What do other traders have to say about MLTX?
One of the reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to see what other traders have to say.
Step 5: Place your MLTX buy order
There are two main options:
- Market order: A market order is an order to buy or sell a stock at the best possible price.
Market orders are generally the easiest way to buy. - Limit order: A limit order lets you buy or sell a security at a specific price (or better).
If you want to make sure you're buying or selling at a particular dollar amount limit, use a limit order.
Hit the Open Trade button and your broker will execute your order.
If you need additional assistance investing in stocks on eToro, click the helpful video below:
Step 6: Get the latest news on your MLTX position
Now that you own some MLTX stock, you'll want to keep up with your new stock purchase.
Put MLTX on a watchlist to get the latest updates about your MLTX stock.
MLTX Feed
How to Buy Stock in Moonlake Immunotherapeutics
To reiterate, here are the 6 steps to buy stock in Moonlake Immunotherapeutics:
- Figure out where to buy Moonlake Immunotherapeutics stock
- Sign up for your brokerage account
- Fund your brokerage account
- Analyze Moonlake Immunotherapeutics stock
- Place your MLTX buy order
- Get the latest news on your MLTX position
If you are looking for a online brokerage, eToro is our favorite venue.
Get Started with eToro TodayIf you would like to keep an eye on your new investment in Moonlake Immunotherapeutics, add MLTX to your watchlist by clicking the button below.
More Content You Might Enjoy
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.